Efficacy and Safety Study of Celecoxib and Pregabalin Compared With Celecoxib Monotherapy, in Patients With Chronic Low Back Pain Having a Neuropathic Component

NCT01838044 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

180

Enrollment

INDUSTRY

Sponsor class

Stopped Recruitment terminated on 3Apr2015 due to slow recruitment rate and lack of operational feasibility. Study was not terminated for reasons of safety/efficacy.

Conditions

Chronic Low Back Pain With a Neuropathic Component

Interventions

DRUG: pregabalin and celecoxib
DRUG: Placebo and celecoxib

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.